MiniMed Group, Inc. (MMED): Revenue

Annual figures by period end, from SEC filings.

$3.10B

Year ended 2026-04-24

$3.22B

Trailing 12 months to 2026-07-31

2024-04-26 Revenue (USD) 2026-04-24

Period ended	Revenue	Change YoY	Source filing
2026-04-24	$3.10B	+14.3%	2026-06-29, From 2025-04-26
2025-04-25	$2.71B	+10.0%	2026-06-29, From 2024-04-27
2024-04-26	$2.47B	n/a	2026-06-29, From 2023-04-29

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
MiniMed Group, Inc. (MMED)	2026-04-24	$3.10B	+14.3%
West Pharmaceutical Services Inc (WST)	2025-12-31	$3.07B	+6.3%
Globus Medical Inc (GMED)	2025-12-31	$2.94B	+16.7%
Insulet Corp (PODD)	2025-12-31	$2.71B	+30.7%
ICU Medical Inc (ICUI)	2025-12-31	$2.23B	-6.3%
Dexcom Inc (DXCM)	2025-12-31	$4.66B	+15.6%
Teleflex Inc (TFX)	2025-12-31	$1.99B	+17.2%
ResMed Inc (RMD)	2026-06-30	$5.65B	+9.9%
Integra Lifesciences Holdings Corp (IART)	2025-12-31	$1.64B	+1.5%

Compare MMED, WST, GMED, PODD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗